A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
NiKang Therapeutics, Inc.
AstraZeneca
Eli Lilly and Company
Kivu Bioscience Inc.
National Cancer Institute (NCI)
Pfizer
Exscientia AI Limited
Conjupro Biotherapeutics, Inc.
Wake Forest University Health Sciences
Sotio Biotech Inc.
Radiopharm Theranostics, Ltd
National Cancer Institute (NCI)
PMV Pharmaceuticals, Inc
NeoImmuneTech
Monte Rosa Therapeutics, Inc
Radiopharm Theranostics, Ltd
MacroGenics
SystImmune Inc.
SN BioScience